Pharmaceuticals, Biotechnology and Life Sciences
STELLAR trial demonstrated a promising median overall survival of 18.2 months when the NovoTTF-100L™ System was added to standard chemotherapies…
PETACH TIKVA, Israel–(BUSINESS WIRE)–Can-Fite BioPharma Ltd. (NYSE American: CANF), a biotechnology company with a pipeline of proprietary small molecule drugs…
– Results of randomized Phase 3 REACH2 trial show that ruxolitinib significantly improves overall response rate (ORR) at 28 days…
— XCUR17 clinical results announced in presentation at the 15th Annual Meeting of the Oligonucleotide Therapeutics Society in Munich —…
DUBLIN–(BUSINESS WIRE)–The “Global NGS Sample Preparation Market – Forecast to 2025” report has been added to ResearchAndMarkets.com’s offering. The NGS…
– AURORA Phase 3 results with voclosporin for the treatment of lupus nephritis remain on track to be reported by…
CertainT Platform Complemented by Stable-Isotopic Indicators Offers Brand Owners Increased Supply Chain Transparency and Product and Process Authentication STONY BROOK,…
GammaDelta Therapeutics spins-out new company to accelerate antibody-based assets towards clinical studies LONDON–(BUSINESS WIRE)–GammaDelta Therapeutics, a company focussed on harnessing…
CHENGDU, China–(BUSINESS WIRE)–HitGen Inc. today announced that it has entered into a drug discovery research collaboration with Galapagos NV to…
Healx has secured %56 million n the latest round of funding, which it intends to use for bulding a clinical-stage…